Format

Send to

Choose Destination
Circulation. 2012 Jan 3;125(1):159-64; discussion 164. doi: 10.1161/CIRCULATIONAHA.111.031146.

Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.

Author information

1
Duke Clinical Research Institute, 2400 Pratt St, Room 0311, Terrace Level, Durham, NC 27705, USA. grang001@mc.duke.edu
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center